BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study

Area of Science:

• Genetics
• Osteoporosis Research
• Bone Biology

Background:

• Bone morphogenetic protein 2 (BMP-2) is crucial for osteoblast differentiation.
• Previous studies suggested BMP-2 gene variations link to osteoporosis, but evidence remains inconclusive.
• This study investigates two specific BMP-2 gene polymorphisms and their association with osteoporosis markers.

Purpose of the Study:

• To examine the association of BMP-2 gene polymorphisms (Ser37Ala and Arg190Ser) with bone mineral density (BMD), bone loss, hip structural analysis (HSA), and fracture risk.
• To evaluate the role of specific BMP-2 haplotypes in osteoporosis development.
• To clarify the relationship between BMP-2 gene variations and osteoporosis in a large, prospective cohort.

Main Methods:

• Genotyping for BMP-2 Ser37Ala and Arg190Ser polymorphisms in 6353 individuals from the Rotterdam Study.
• Inferred BMP-2 haplotypes using PHASE software.
• Analyzed associations with BMD, bone loss, HSA parameters, and fractures using AN(C)OVA and Cox proportional-hazards models, adjusting for age, height, and weight.

Main Results:

• Determined allele frequencies for Ser37Ala (2.5% Ala37) and Arg190Ser (40.2% Ser190).
• Identified haplotype allele frequencies: Ser37Arg190 (57.28%), Ser37Ser190 (40.19%), Ala37Arg190 (2.50%), and Ala37Ser190 (0.02%).
• Found no significant differences in BMD, bone loss, HSA outcomes, or fracture incidence between genotype and haplotype groups.

Conclusions:

• The BMP-2 Ser37Ala and Arg190Ser polymorphisms and their haplotypes are not associated with osteoporosis parameters in this large population-based cohort of Dutch whites.
• These specific BMP-2 variants do not appear to be significant risk factors for osteoporosis in the studied population.
• Further research may be needed to explore other genetic factors influencing osteoporosis.